INMB · Categories · Form 4

INMB - SEC Form 4 insider transactions

INmune Bio Inc. (INMB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for INMB

• 150d
  SEC Form 4 filed by Chief Executive Officer Moss David J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 150d
  SEC Form 4 filed by Chief Scientific Officer Lowdell Mark William

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 150d
  SEC Form 4 filed by INmune Bio Inc.

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 150d
  SEC Form 4 filed by Director Schroeder Timothy J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 150d
  SEC Form 4 filed by Director Juda Scott

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 150d
  SEC Form 4 filed by INmune Bio Inc.

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 150d
  SEC Form 4 filed by Director Allen Marcia

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 164d
  SEC Form 4 filed by Director Schroeder Timothy J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 164d
  SEC Form 4 filed by Chief Executive Officer Moss David J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 164d
  SEC Form 4 filed by Chief Scientific Officer Lowdell Mark William

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 164d
  SEC Form 4 filed by Director Juda Scott

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 164d
  SEC Form 4 filed by Director Ganjei James Kelly

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 164d
  SEC Form 4 filed by Interim CFO Ellspermann Cory Randall

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 164d
  SEC Form 4 filed by Director Allen Marcia

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 508d
  SEC Form 4 filed by Director Ganjei James Kelly

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 508d
  SEC Form 4 filed by Director Juda Scott

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 508d
  SEC Form 4 filed by Director Allen Marcia

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 508d
  SEC Form 4 filed by Chief Scientific Officer Lowdell Mark William

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 508d
  SEC Form 4 filed by Director Schroeder Timothy J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 508d
  SEC Form 4 filed by Chief Financial Officer Moss David J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 508d
  SEC Form 4 filed by President and CEO Tesi Raymond Joseph

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 688d
  SEC Form 4 filed by President and CEO Tesi Raymond Joseph

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 715d
  SEC Form 4 filed by Tesi Raymond Joseph

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 715d
  SEC Form 4 filed by Schroeder Timothy J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 715d
  SEC Form 4 filed by Moss David J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 715d
  SEC Form 4 filed by Lowdell Mark William

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 715d
  SEC Form 4 filed by Juda Scott

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 715d
  SEC Form 4 filed by Ganjei James Kelly

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 715d
  SEC Form 4 filed by Baracchini Edgardo Jr

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 715d
  SEC Form 4 filed by Allen Marcia

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 738d
  Tesi Raymond Joseph was granted 18,028 shares, increasing direct ownership by 1% to 1,538,726 units (SEC Form 4)

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 738d
  Moss David J was granted 18,028 shares, increasing direct ownership by 1% to 1,268,179 units (SEC Form 4)

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 738d
  Lowdell Mark William was granted 14,423 shares, increasing direct ownership by 0.96% to 1,510,806 units (SEC Form 4)

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 738d
  Juda Scott was granted 29,603 shares, increasing direct ownership by 80% to 66,603 units (SEC Form 4)

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1022d
  SEC Form 4 filed by Schroeder Timothy J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1139d
  SEC Form 4 filed by INmune Bio Inc.

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1165d
  SEC Form 4 filed by Tesi Raymond Joseph

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1165d
  SEC Form 4 filed by Juda Scott

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1165d
  SEC Form 4 filed by Schroeder Timothy J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1165d
  SEC Form 4 filed by Moss David J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1165d
  SEC Form 4 filed by Ganjei James Kelly

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1165d
  SEC Form 4 filed by Baracchini Edgardo Jr

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1165d
  SEC Form 4 filed by Allen Marcia

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1432d
  SEC Form 4: Tesi Raymond Joseph bought $40,383 worth of shares (6,300 units at $6.41), increasing direct ownership by 0.42% to 1,520,698 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1432d
  SEC Form 4: Moss David J bought $68,649 worth of shares (10,700 units at $6.42), increasing direct ownership by 0.87% to 1,247,651 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1500d
  SEC Form 4: Lowdell Mark William was granted 23,590 shares, increasing direct ownership by 2% to 1,496,383 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1500d
  SEC Form 4: Tesi Raymond Joseph was granted 23,724 shares, increasing direct ownership by 2% to 1,514,398 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1500d
  SEC Form 4 filed by Schroeder Timothy J

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1500d
  SEC Form 4: Moss David J was granted 17,793 shares, increasing direct ownership by 1% to 1,236,951 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1500d
  SEC Form 4 filed by Juda Scott

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1500d
  SEC Form 4: Ganjei James Kelly was granted 17,793 shares

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1500d
  SEC Form 4 filed by Baracchini Edgardo Jr

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1500d
  SEC Form 4 filed by Allen Marcia

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1626d
  SEC Form 4: Juda Scott bought $33,875 worth of shares (2,500 units at $13.55)

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1639d
  SEC Form 4: Moss David J sold $20,500 worth of shares (1,025 units at $20.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 1,219,158 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1639d
  SEC Form 4: Lowdell Mark William sold $14,020 worth of shares (701 units at $20.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.05% to 1,472,793 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1639d
  SEC Form 4: Tesi Raymond Joseph sold $72,520 worth of shares (3,626 units at $20.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.24% to 1,490,674 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1645d
  SEC Form 4: Tesi Raymond Joseph sold $130,340 worth of shares (6,517 units at $20.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.43% to 1,494,300 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1645d
  SEC Form 4: Lowdell Mark William sold $47,140 worth of shares (2,357 units at $20.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.16% to 1,473,494 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)
• 1645d
  SEC Form 4: Moss David J sold $41,580 worth of shares (2,079 units at $20.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.17% to 1,220,183 units

  4 - Inmune Bio, Inc. (0001711754) (Issuer)

Other INMB categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends